サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463711

北米の糖尿病性足潰瘍：2030年市場予測-地域別分析：潰瘍タイプ、治療タイプ、感染重症度、エンドユーザー別

North America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 109 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米の糖尿病性足潰瘍：2030年市場予測-地域別分析：潰瘍タイプ、治療タイプ、感染重症度、エンドユーザー別
出版日: 2024年02月05日
発行: The Insight Partners
ページ情報: 英文 109 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の糖尿病性足潰瘍市場は、2022年に35億7,076万米ドルと評価され、2030年には59億4,356万米ドルに達すると予測され、2022年から2030年までのCAGRは6.6%で成長すると予測されています。

創傷ケア管理における3Dプリンティングの利用が北米の糖尿病性足潰瘍市場を促進

糖尿病や血管疾患による様々な適応症によって引き起こされる皮膚組織の損傷は、ヘルスケアシステムに大きな負担を強いています。3Dバイオプリンティングは、レイヤーベースの合成に基づいており、新たに生成された細胞や細胞ベースの材料は、ネイティブ組織を模倣するために分配することができます。この技術はまだ始まったばかりだが、3Dプリンティングは創傷治療業界に革命を起こす可能性があります。多くの企業が、真皮再生のための血管新生を促進するイオン放出生体材料を含む新製品の開発に携わっています。さらに、3Dバイオプリンティングは、標準的な技術では治癒が難しい大きな傷の応急処置にも役立ちます。潰瘍や創傷の治療に3Dバイオプリンティング技術を使用することは、今後数年間、糖尿病性足潰瘍市場の顕著な傾向として現れる可能性が高いです。

北米の糖尿病性足潰瘍市場概要

北米の糖尿病性足潰瘍市場は、2022年から2030年にかけてCAGR 6.64%で成長すると推定されます。市場成長を促進する主な要因は、糖尿病とそれに関連する慢性創傷の有病率の増加と老人人口の増加です。しかし、高度な創傷治療には高いコストがかかるため、市場成長の妨げとなっています。また、この地域における老人人口の増加も市場成長を後押ししています。2022年に発表された高齢化対策局（米国保健福祉省）の報告書によると、2020年の米国の65歳以上の高齢者人口は5,570万人でした。この高齢者層は人口の17％を占め、i.e.アメリカ人の6人に1人にあたる。アーバン・インスティテュート（ワシントンDCを拠点とするシンクタンク）の推定によると、65歳以上の人口は今後40年間で倍増し、2040年には米国で8,000万人に達します。さらに2020年には、糖尿病が65歳以上の成人における主要な慢性疾患のひとつになると考えられています。

近年、北米における糖尿病性足潰瘍市場の拡大を加速させるために、いくつかの合弁事業、イニシアティブ、提携が貢献しています。例えば、2020年には米国の6つの研究機関が米国国立衛生研究所の資金提供を受け、糖尿病性足潰瘍を研究する初の多施設ネットワークを立ち上げました。さらにカナダでは、糖尿病性足合併症の予防を目的としたDiabetic Foot Canadaプログラムが開始されました。このように、糖尿病有病率の高さと老年人口の増加が、この地域の市場成長を促進します。

北米の糖尿病性足潰瘍市場の収益と2030年までの予測（金額）

北米の糖尿病性足潰瘍市場のセグメンテーション

北米の糖尿病性足潰瘍市場は、治療タイプ別に高度創傷被覆材、治療機器、生物学的製剤に区分されます。2022年には、高度創傷治療用ドレッシング材セグメントが最大のシェアを占めました。

潰瘍のタイプに基づき、北米の糖尿病性足潰瘍市場は神経虚血性潰瘍、神経障害性潰瘍、虚血性潰瘍に区分されます。神経虚血性潰瘍セグメントが2022年に最大のシェアを占めました。

感染の重症度に基づき、北米の糖尿病性足潰瘍市場は軽度、中等度、重度に区分されます。2022年には軽度のセグメントが最大のシェアを占めました。

エンドユーザー別では、北米の糖尿病性足潰瘍市場は病院、外来手術センター、在宅医療に区分されます。病院セグメントが2022年に最大シェアを占めました。

国別では、北米の糖尿病性足潰瘍市場は米国、カナダ、メキシコに区分されます。2022年の北米糖尿病性足潰瘍市場は米国が支配的でした。

Convatec Group Plc、3M Co、Coloplast AS、Smith &Nephew Plc、B. Braun SE、Medline Industries LP、Organogenesis Inc、Molnlycke Health Care AB、MiMedx Group Incは、北米の糖尿病性足潰瘍市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の糖尿病性足潰瘍市場情勢

第5章 北米の糖尿病性足潰瘍市場：主要産業力学

  • 市場促進要因
    • 糖尿病および関連する慢性創傷の高い有病率
    • 老人人口の急増
  • 市場抑制要因
    • 高度な創傷治療費用の高騰
  • 市場機会
    • 新しい創傷治療製品を発表するための調査活動の活発化
  • 今後の動向
    • 創傷治療管理における3Dプリンティングの利用
  • インパクト分析

第6章 糖尿病性足潰瘍市場：北米市場分析

  • 北米の糖尿病性足潰瘍市場収益、2022年～2030年

第7章 北米の糖尿病性足潰瘍市場-2030年までの収益と予測-治療タイプ別

  • 北米糖尿病性足潰瘍市場2022年・2030年治療タイプ別売上高シェア（%）
  • 先進創傷ケアドレッシング
  • 生物製剤
  • 治療デバイス

第8章 北米糖尿病性足潰瘍市場：潰瘍タイプ別収益と2030年までの予測

  • 北米の糖尿病性足潰瘍市場：2022年および2030年の潰瘍タイプ別売上高シェア（%）
  • 神経障害性潰瘍
  • 虚血性潰瘍
  • 神経虚血性潰瘍

第9章 北米糖尿病性足潰瘍市場：2030年までの収益と予測：感染重症度別

  • 北米糖尿病性足潰瘍市場2022年および2030年感染重症度別売上高シェア（%）
  • 軽症、中等症、重症

第10章 北米糖尿病性足潰瘍市場：エンドユーザー別収益と2030年までの予測

  • 北米の糖尿病性足潰瘍市場：エンドユーザー別収益シェア（2022年および2030年）
  • 病院
  • 外来手術センター
  • 在宅医療

第11章 糖尿病性足潰瘍市場-北米市場分析

  • 北米の糖尿病性足潰瘍市場、収益と2030年までの予測
      • 北米の糖尿病性足潰瘍市場：国別
      • 米国
      • カナダ
      • メキシコ

第12章 北米の糖尿病性足潰瘍市場の業界情勢

  • 世界の糖尿病性足潰瘍市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 北米糖尿病性足潰瘍市場-主要企業プロファイル

  • Convatec Group Plc
  • 3M Co
  • Coloplast AS
  • Smith & Nephew Plc
  • B. Braun SE
  • Molnlycke Health Care AB
  • MiMedx Group Inc
  • Medline Industries LP
  • Organogenesis Inc.

第14章 付録

図表

List Of Tables

  • Table 1. North America Diabetic Foot Ulcer Market Segmentation
  • Table 2. Middle East & Africa Diabetic Foot Ulcer Market, by Country - Revenue and Forecast to 2030 (USD Million)
  • Table 3. US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Ulcer Type
  • Table 4. US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 5. US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings - Revenue and Forecast to 2030 (USD Million)
  • Table 6. US: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
  • Table 7. US: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
  • Table 8. US Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - Infection Severity
  • Table 9. US Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 10. Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Ulcer Type
  • Table 11. Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 12. Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Canada: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
  • Table 14. Canada: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
  • Table 15. Canada Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - Infection Severity
  • Table 16. Canada Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Ulcer Type
  • Table 18. Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 19. Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Mexico: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
  • Table 21. Mexico: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
  • Table 22. Mexico Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - Infection Severity
  • Table 23. Mexico Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 24. Recent Inorganic Growth Strategies in the Global Diabetic Foot Ulcer Market
  • Table 25. Recent Organic Growth Strategies in the Global Diabetic Foot Ulcer Market
  • Table 26. Glossary of Terms, Diabetic Foot Ulcer Market

List Of Figures

  • Figure 1. North America Diabetic Foot Ulcer Market Segmentation, By Country
  • Figure 2. North America Diabetic Foot Ulcer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • Figure 6. Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Alginate Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Hydrofiber Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Foam Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Collagen Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Film Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Other Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Biologics: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Growth Factors: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Skin Graft: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Therapy Device: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Negative Pressure Wound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ultrasound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
  • Figure 20. Neuropathic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
  • Figure 24. Mild: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Moderate: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Severe: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. North America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
  • Figure 28. Hospitals: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Home Care: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. North America Diabetic Foot Ulcer Market, By Key Countries 2022 (US$Mn)
  • Figure 32. North America Diabetic Foot Ulcer Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Growth Strategies in the Global Diabetic Foot Ulcer Market
目次
Product Code: BMIRE00029570

The North America diabetic foot ulcer market was valued at US$ 3,570.76 million in 2022 and is expected to reach US$ 5,943.56 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Use of 3D Printing in Wound Care Management Fuels the North America Diabetic Foot Ulcer Market.

Skin tissue damage caused by various indications due to diabetes and vascular diseases significantly burdens the healthcare systems. 3D bioprinting is based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still nascent, 3D printing can potentially revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that promote angiogenesis for dermal regeneration. In addition, 3D bioprinting helps patch large wounds that are hard to heal with standard techniques. The use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer market in the coming years.

North America Diabetic foot ulcer Market Overview

The North America diabetic foot ulcer market is estimated to grow at a CAGR of 6.64% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth. The growing geriatric population in the region also boosts the market growth. According to the Administration on Aging (US Department of Health and Human Services) report published in 2022, there were 55.7 million people aged 65 and above in 2020 in the US. The old age group represents 17% of the population, i.e., 1 in every 6 Americans. As per estimates by the Urban Institute (Washington, DC-based think tank), the number of people aged 65 and older will double over the next 40 years, reaching 80 million in 2040 in the US. Additionally, in 2020, diabetes is regarded as among the leading chronic conditions among adults aged 65 and above.

In recent years, several joint ventures, initiatives, and collaborations contributed to accelerating the diabetic foot ulcers market expansion in North America. For instance, in 2020, six research institutions in the US launched the first-ever multicenter network funded by the National Institutes of Health to study diabetic foot ulcers in the US. Additionally, the Diabetic Foot Canada program was launched in Canada to prevent diabetic foot complications. Thus, the high prevalence of diabetes and the increasing geriatric population will drive the market growth in the region.

North America Diabetic foot ulcer Market Revenue and Forecast to 2030 (US$ Million)

North America Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the North America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the North America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the North America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the North America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the North America diabetic foot ulcer market is segmented into US, Canada, and Mexico. The US dominated North America diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the North America diabetic foot ulcer market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Diabetic Foot Ulcer Market Landscape

  • 4.1 Overview

5. North America Diabetic Foot Ulcer Market - Key Industry Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
    • 5.1.2 Surge in Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Advanced Wound Care Treatments
  • 5.3 Market Opportunities
    • 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
  • 5.4 Future Trends
    • 5.4.1 Use of 3D Printing in Wound Care Management
  • 5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market - North America Market Analysis

  • 6.1 North America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

  • 7.1 Overview
  • 7.2 North America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • 7.3 Advanced Wound Care Dressings
    • 7.3.1 Overview
    • 7.3.2 Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Alginate Dressings
      • 7.3.3.1 Overview
      • 7.3.3.2 Alginate Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Hydrofiber Dressings
      • 7.3.4.1 Overview
      • 7.3.4.2 Hydrofiber Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Foam Dressings
      • 7.3.5.1 Overview
      • 7.3.5.2 Foam Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Collagen Dressing
      • 7.3.6.1 Overview
      • 7.3.6.2 Collagen Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.7 Film Dressing
      • 7.3.7.1 Overview
      • 7.3.7.2 Film Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.8 Other Dressings
      • 7.3.8.1 Overview
      • 7.3.8.2 Other Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biologics
    • 7.4.1 Overview
    • 7.4.2 Biologics: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Growth Factors
      • 7.4.3.1 Overview
      • 7.4.3.2 Growth Factors: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Skin Graft
      • 7.4.4.1 Overview
      • 7.4.4.2 Skin Graft: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Therapy Device
    • 7.5.1 Overview
    • 7.5.2 Therapy Device: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.3 Negative Pressure Wound Therapy
      • 7.5.3.1 Overview
      • 7.5.3.2 Negative Pressure Wound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.4 Ultrasound Therapy
      • 7.5.4.1 Overview
      • 7.5.4.2 Ultrasound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

  • 8.1 Overview
  • 8.2 North America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
  • 8.3 Neuropathic Ulcers
    • 8.3.1 Overview
    • 8.3.2 Neuropathic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ischemic Ulcers
    • 8.4.1 Overview
    • 8.4.2 Ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neuro-ischemic Ulcers
    • 8.5.1 Overview
    • 8.5.2 Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

  • 9.1 Overview
  • 9.2 North America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
  • 9.3 Mild, Moderate, and Severe
    • 9.3.1 Overview
    • 9.3.2 Mild: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Moderate: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Severe: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

  • 10.1 Overview
  • 10.2 North America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Home Care
    • 10.5.1 Overview
    • 10.5.2 Home Care: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - North America Market Analysis

  • 11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
      • 11.1.1.1 North America Diabetic Foot Ulcer Market, by Country
      • 11.1.1.2 US
        • 11.1.1.2.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 US Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.1.2.3 US Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.1.2.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.1.2.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.1.2.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.1.2.4 US Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.1.2.5 US Diabetic Foot Ulcer Market, by End User
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.1.3.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.1.3.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.1.3.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.1.3.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.1.3.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.1.3.5 Canada Diabetic Foot Ulcer Market, by End User
      • 11.1.1.4 Mexico
        • 11.1.1.4.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.1.4.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.1.4.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.1.4.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.1.4.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.1.4.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.1.4.5 Mexico Diabetic Foot Ulcer Market, by End User

12. North America Diabetic Foot Ulcer Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. North America Diabetic Foot Ulcer Market - Key Company Profiles

  • 13.1 Convatec Group Plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 3M Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Coloplast AS
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Smith & Nephew Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 B. Braun SE
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Molnlycke Health Care AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 MiMedx Group Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Medline Industries LP
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Organogenesis Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms